University College London (UCL)

Boy given world-first gene therapy made by UCL scientists ‘thriving’

A young boy born with a devastating, rare genetic condition has been given a new lease of life thanks to a team of UCL ...
Business Wire

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife ® System

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Nature

CHU UCL Namur - Sainte-Elisabeth Hospital

Article ‘Count’ and ‘Share’ for CHU UCL Namur - Sainte-Elisabeth Hospital based on listed parameters only. The articles listed below published by authors from CHU UCL Namur - Sainte-Elisabeth Hospital ...
Nasdaq

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

Investigator initiated trial seeks to validate safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying need for radical intervention Approximately 40% of all ...
Post Register

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...